Not Yet RecruitingNot Applicable

Foreign-National Burn Patients in a Border-Region Burn Center

1,400 participantsStarted 2026-07

Plain-language summary

This retrospective cohort study will evaluate burn patients hospitalized and treated at the Burn Center of Gaziantep City Hospital between October 2023 and June 2026. The study aims to compare demographic characteristics, burn severity, clinical course, and in-hospital outcomes between Turkish citizens and foreign-national burn patients. Data will be obtained retrospectively from patient files, discharge summaries, intensive care records, operative notes, and the hospital information management system. Variables will include age, sex, nationality status, burn etiology, total body surface area burned, inhalation injury, sepsis, intensive care unit admission, mechanical ventilation requirement, surgical treatment requirement, number of operations, length of hospital stay, discharge status, transfer to another center, and in-hospital mortality. No additional intervention, diagnostic test, treatment, or follow-up procedure will be performed as part of this study. All analyses will be conducted using anonymized or coded retrospective clinical data.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients hospitalized and treated with a diagnosis of burn injury at the Burn Center of Gaziantep City Hospital between October 2023 and June 2026. Patients with a confirmed diagnosis of burn injury in patient files, discharge summaries, or hospital information management system records. Patients whose nationality status can be classified as Turkish citizen or foreign-national according to hospital records. Patients with available basic demographic, clinical, and in-hospital outcome data. Patients of all age groups and both sexes. Exclusion Criteria: Patients treated outside the predefined study period. Patients without a confirmed diagnosis of burn injury. Patients evaluated only in the outpatient setting without hospitalization. Patients with missing nationality data. Patients with insufficient demographic or clinical outcome data for analysis. Duplicate records related to the same burn event; only the first hospitalization will be included. Patients evaluated only for consultation without hospitalization at the Burn Center of Gaziantep City Hospital. \-

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

In-hospital mortality

Timeframe: From hospital admission to hospital discharge, transfer to another center, or death, assessed retrospectively up to September 2026.

Trial details

NCT IDNCT07673796

SponsorGaziantep City Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09

Contact for this trial

Bekir Suat Kürkçüoğlu, MD

+90 505 583 04 63 bekirsuat@gmail.com

View on ClinicalTrials.gov More Burn Injury trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.